期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

移植后糖尿病的相关基因多态性研究进展 被引量：3

下载PDF
导出
摘要 移植后糖尿病（posttransplantation diabetes mellitus，PTFDM）是肾移植术后常见的并发症，是导致慢性移植肾功能障碍、移植物失功的主要原因，明显降低移植物和患者的存活率，
作者 余爱荣 范星
机构地区 广州军区武汉总医院临床药理科 广州军区武汉总医院肾病内科
出处 《中国药师》 CAS 2011年第3期359-362,372,共5页 China Pharmacist
关键词 移植后糖尿病 易感基因 基因多态性 高危因素
分类号 R968 [医药卫生—药理学]
  • 相关文献

参考文献27

  • 1Cosio FG, Pesavento TE, Kim S,et al. Patient survival after renal trans- plantation:IV. Impact of post-transplant diabetes[ J ]. Kidney Int ,2002, 62 (4) : 1440-1446.
  • 2余爱荣,辛华雯,吴笑春,李罄.含环孢素的三联免疫治疗方案对肾移植受者糖耐量的影响[J].药物流行病学杂志,2007,16(5):277-279. 被引量：8
  • 3Bahar J, Ortega T, Ortega F, et al. Posttransplantation diabetes melli- tus : prevalence and risk factors [ J ]. Transplant Proc, 2005,37 ( 9 ) : 3817-3818.
  • 4辛华雯,吴笑春.免疫抑制药与移植后糖尿病[J].中国药师,2008,11(7):799-802. 被引量：6
  • 5PermuttMA, Bernal ME, Inoue H. Calpain 10 : the first positional clo- ning of a gene for type 2 diabetes[J]. J Clin Invest,2000,106:819.
  • 6Cox NJ, Hayes MG. Linkage of calpain 10 to type 2 diabetes[ J]. D/a- betes ,2004,53 : S19.
  • 7Mateusz K, Krzysztof D, Karolina K,et al. Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus [ J ]. Pharmacogenomics Journal,2010,10:120-125.
  • 8Grant SF, Thorleifsson G, Reynisdottir I,et al. Variant of transcription factor 7-like 2 (TCFTL2 ) gene confers risk of type 2 diabetes[ J]. Nat Genet ,2006,38 ( 3 ) :320-323.
  • 9Chang YC, Chang TJ, Jiang YD, et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2(TCFTL2) gene and type 2 diabetes in the Chinese population [ J ]. Diabetes, 2007,56 (10) :2631-2637.
  • 10Ng MC ,Tam CH, Lam VK, et al. Replication and identification of no- vel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese[ J]. J Clin Endocrinol Metab ,2007,92 (9) :3733-3737.

二级参考文献43

  • 1中华医学会眼科学会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42-42.
  • 2傅祖植.糖尿病[A].见叶任高主编.内科学:第5版[C].北京:人民卫生出版社,2000.798～825.
  • 3Lee S,Clark SA,Gill RK,et al.1,25-dihydroxyvitamin D3 and pancreatic β-cell function:vitamin D receptors,gene expression and insulin secretion.Endocrinology,1994,134:1602-1610.
  • 4Graham GA,Mannan N,McDermott MF,et al.Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladesh Asians.Diabetes,1998,47:668-690.
  • 5Walsh PS,Metzger DA,Higuchi R.Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material.Biotechniques,1991,10:506-513.
  • 6Bassam BJ,Caetano-Anolles G,Gresshoff PM.Fast and sensitive silver staining of DNA in polyacrylamide gels.Anal Biochem,1991,196:80-83.
  • 7Newton CR,Graham A,Hentinstall LE,et al.Analysis of any point mutation in DNA.The amplitication refractory mutation system (ARMS).Nucleic Acids Res,1989,17:2503.
  • 8Norman AW.The vitamin D endocrine system:identification of another piece of the puzzle.Endocrinology,1994,134:1601A-1601C.
  • 9Sergeev IN,Rhoten WB.1,25-dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic β-cell line.Endocrinology,1995,136:2852-2861.
  • 10Borissova AM,Tankova T,Kirilov G,et al.The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2diabetic patients.Int J Clin Pract,2003,57:258-261.

共引文献20

同被引文献44

  • 1吕铁明,谭建明.转化生长因子β1基因型与移植肾慢性排斥反应的关系[J].中国医药生物技术,2007,2(1):28-31. 被引量：2
  • 2李川江,于立新,徐健,付绍杰,邓文锋,杜传福,王亦斌.转化生长因子β1基因多态性与慢性移植肾肾病的关系[J].南方医科大学学报,2007,27(4):535-537. 被引量：3
  • 3周惠忠,黎磊石.肾移植排异反应的机理与诊断.国际泌尿系统杂志,1987,2:15-17.
  • 4Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal transplant survival. Lancet, 2001, 357: 1758-1761.
  • 5Ro H, Hwang YH, Kim H, et al. Association of polymorphisms of interleukin-8, CXCR1, CXCR2, and selectin with allograft outcomes in kidney transplantation. Transplantation, 2011, 91: 57-64.
  • 6Rosso FC, De Sandes TV, Sampaio EL, et al. Clinical impact of polymorphisms of transport proteins and enzymes involved in the metabolism of immunosuppressive drugs. Transplant Proc, 2009, 41: 1441-1455.
  • 7Grenda R, Prokurat S, Ciechanowicz A, et al. Evaluation of the genetic background of standard-immtmosuppressant-related toxicity in a cohort of 200 paediatricrenal allograft recipients: a retrospective study. Ann Transplant, 2009, 14: 18-24.
  • 8Ozdemir V, Kalow W, Tang BK, et al. Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics, 2000, 10: 373-388.
  • 9Hesselink DA, van Schaik RI-I, van der Heiden IP, et al. Genetic polymorphisms of the CYIA4, CYP3AS, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. Clin Pharmacol Ther, 2003, 74: 245-254.
  • 10Roy JN, Bamma A, Poirier C, et al. CYP3A4, CYP3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics inrenal transplant recipients. Pharmacogenet Genomics, 2006, 16: 659-665.

引证文献3

二级引证文献3

中国药师
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部